Microbiome
At the heart of Named Group’s research and innovation activities – particularly in the field of microbiota – is the idea of the human being as a holobiont, i.e. a host organism together with all the other microorganisms that inhabit it. Through the adoption of “shotgun sequencing technology”, which in the context of Next-Generation Sequencing (NGS) allows the simultaneous sequencing of all the DNA of all the microorganisms (bacteria, viruses, fungi and parasites) present in vaginal and intestinal ecosystems, and thanks to an advanced and proprietary method of metagenomic interpretation, Named Group offers microbiota tests which provide a taxonomic snapshot that is highly useful thanks to the completeness and reliability of the analysis.
MICROBIOTA ANALYSIS
The human microbiota is the population of microorganisms – bacteria, viruses, fungi, protozoa – that live on and in the body. Specifically, gut microbiota refers to the microbial ecosystem in the intestinal tract that performs metabolic, immunological and protective functions that are essential for the wellbeing of the entire organism, and whose balance defined as “eubiosis” is fundamental for maintaining and recovering wellbeing. Eubiosis is also defined as the balance of the vaginal microbiota. Throughout a woman’s life, and especially during the menopause, there are many internal and external factors that influence the vaginal microbiota, modifying its composition and favouring pathological conditions that can become chronic or recurrent, greatly impacting quality of life. Knowing the state of “eubiosis” of the intestinal and vaginal microbiota is an important element for maintaining our wellbeing and, when necessary, helping our doctor and pharmacist to identify an increasingly precise and personalised treatment pathway.
